Skip to main content
Hualan Biological Engineering Inc. logo

Hualan Biological Engineering Inc. — Investor Relations & Filings

Ticker · 002007 ISIN · CNE000001JN8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,526 across all filing types
Latest filing 2023-03-29 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002007

About Hualan Biological Engineering Inc.

https://www.hualanbio.com

Hualan Biological Engineering Inc. is a biopharmaceutical enterprise specializing in the research, development, production, and commercialization of blood products and vaccines. The company’s portfolio is divided into two primary segments: plasma-derived therapeutics and viral vaccines. Key blood products include human albumin, intravenous immunoglobulin (IVIG), human coagulation factor VIII, and prothrombin complex. In the vaccine sector, the company produces seasonal influenza vaccines, including quadrivalent formulations, as well as hepatitis B and rabies vaccines. Hualan Biological Engineering operates advanced manufacturing facilities and plasma collection centers, focusing on high-quality standards and technological innovation in recombinant protein drugs and monoclonal antibodies to address critical medical needs in immunology, hematology, and infectious disease prevention.

Recent filings

Filing Released Lang Actions
2022年独立董事年度述职报告(王云龙)
Board/Management Information Classification · 95% confidence The document is a detailed report by an independent director of a company for the year 2022. It includes descriptions of attendance at board meetings, independent opinions on various company matters such as related party transactions, internal control evaluations, audit firm appointments, investment decisions, profit distribution proposals, and board candidate nominations. The content is focused on the independent director's duties and opinions over the fiscal year, which aligns with a formal director's report or management-related report rather than a full annual report or audit report. It is not a transcript, earnings release, or a simple announcement. The document length (6575 characters) and detailed content indicate it is a substantive report. Given the nature of the content, it fits best under Board/Management Information (MANG), which covers announcements related to board or senior management activities and reports. Therefore, the classification is MANG with high confidence.
2023-03-29 Chinese
2022年社会责任报告
Environmental & Social Information Classification · 100% confidence The document is titled as the "2022 Annual Social Responsibility Report" of 华兰生物工程股份有限公司. It details the company's activities and performance related to social responsibility, environmental protection, employee welfare, stakeholder engagement, and sustainable development for the fiscal year 2022. The content focuses on Environmental, Social, and Governance (ESG) factors and the company's social responsibility initiatives rather than financial results or governance structure alone. The length of the document (7366 characters) and the detailed narrative confirm it is a full report, not just an announcement or summary. Therefore, this document fits the category of Environmental & Social Information (SR).
2023-03-29 Chinese
关于使用自有资金进行投资理财的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by a company regarding the use of its own funds for investment and financial management. It details the investment purpose, amount, objects, approval procedures, impact on the company, risk control measures, and independent directors' opinions. The document is relatively short (1381 characters) and does not contain financial statements or detailed financial data. It is an announcement about a capital management decision rather than a financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP).
2023-03-29 Chinese
关于控股子公司取得药品注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the acquisition of a drug registration certificate by a subsidiary of the company. It contains no financial data, no mention of financial results, no regulatory certifications, or meeting materials. It is an official company announcement about a regulatory approval related to product registration. The document length is only 482 characters, indicating it is a brief announcement rather than a detailed report. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not about management changes, voting results, or capital changes. The best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous official announcements that do not fit other categories.
2023-02-27 Chinese
关于全资子公司取得药品注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the acquisition of drug registration certificates by a wholly-owned subsidiary of the company. It contains no financial data, no mention of financial results, no regulatory certifications, or meeting materials. It is an official announcement about a regulatory approval impacting the company's operations. The document length is only 552 characters, indicating it is a brief announcement rather than a detailed report. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-02-24 Chinese
关于控股子公司取得药品注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (470 characters) about a subsidiary obtaining a drug registration certificate from the National Medical Products Administration. It is a regulatory update related to product approval, not a financial report, management change, or shareholder meeting material. It does not contain financial data or detailed report content. It is an official regulatory announcement about a business development event. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-01-31 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.